Seed financing announcement for new ICR and Oxford spinout company Kodiform Therapeutics 11 Jun 2024 Kodiform Therapeutics, a new joint spin-out company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises. Find out more Show/Hide
ICR strategic commercial partner raises $226.5m in financing 18 Sep 2023 Apollo Therapeutics, a strategic partner of The Institute of Cancer Research, has raised more than $226m from investors to fund its ongoing collaboration with the ICR and other academic partners. Find out more Show/Hide